stars 1 stars 2 stars 3

A leader in Prion Detection Science™, Amprion innovates biomarker testing for brain diseases. Our SYNTap® Biomarker Test helps doctors diagnose Lewy Body Variant of Alzheimer's Disease, Parkinson's Disease, and Lewy Body Dementia. Awarded FDA Breakthrough Device Designation for its detection technology, Amprion strives to accelerate precision medicine for neurodegenerative diseases through molecular testing.

Amprion Inc. Questions

The Amprion Inc. annual revenue was $4 million in 2026.

Amprion Inc. is based in Houston, Texas.

The NAICS codes for Amprion Inc. are [8132, 81321, 813, 813212, 81].

The SIC codes for Amprion Inc. are [83, 839].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users